Biohaven Pharmaceutical Holding Stock Price on May 10, 2021
BHVN Stock | USD 38.72 0.89 2.25% |
If you're considering investing in Biohaven Stock, it is important to understand the factors that can impact its price. As of today, the current price of Biohaven Pharmaceutical stands at 38.72, as last reported on the 25th of April, with the highest price reaching 40.62 and the lowest price hitting 38.38 during the day. Biohaven Pharmaceutical secures Sharpe Ratio (or Efficiency) of -0.0409, which signifies that the company had a -0.0409% return per unit of risk over the last 3 months. Biohaven Pharmaceutical Holding exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Biohaven Pharmaceutical's Standard Deviation of 3.86, mean deviation of 2.6, and Risk Adjusted Performance of (0.03) to double-check the risk estimate we provide.
At this time, Biohaven Pharmaceutical's Total Stockholder Equity is very stable compared to the past year. As of the 25th of April 2024, Other Stockholder Equity is likely to grow to about 73.8 M, while Liabilities And Stockholders Equity is likely to drop about 347.2 M. . At this time, Biohaven Pharmaceutical's Price Book Value Ratio is very stable compared to the past year. As of the 25th of April 2024, Price Earnings To Growth Ratio is likely to grow to 0.14, while Price To Sales Ratio is likely to drop 8.54. Biohaven Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Biohaven |
Sharpe Ratio = -0.0409
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | BHVN |
Estimated Market Risk
3.89 actual daily | 34 66% of assets are more volatile |
Expected Return
-0.16 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.04 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Biohaven Pharmaceutical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Biohaven Pharmaceutical by adding Biohaven Pharmaceutical to a well-diversified portfolio.
Price Book 10.1281 | Book Value 5.276 | Enterprise Value 2.8 B | Enterprise Value Ebitda (9.28) | Shares Float 66.7 M |
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
About Biohaven Pharmaceutical Stock history
Biohaven Pharmaceutical investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Biohaven is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Biohaven Pharmaceutical will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Biohaven Pharmaceutical stock prices may prove useful in developing a viable investing in Biohaven Pharmaceutical
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 71.2 M | 51.9 M | |
Net Loss | -513.3 M | -538.9 M |
Biohaven Pharmaceutical Quarterly Net Working Capital |
|
Biohaven Pharmaceutical Stock Technical Analysis
Biohaven Pharmaceutical technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Biohaven Pharmaceutical Period Price Range
Biohaven Pharmaceutical April 25, 2024 Market Strength
Market strength indicators help investors to evaluate how Biohaven Pharmaceutical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Biohaven Pharmaceutical shares will generate the highest return on investment. By undertsting and applying Biohaven Pharmaceutical stock market strength indicators, traders can identify Biohaven Pharmaceutical Holding entry and exit signals to maximize returns
Biohaven Pharmaceutical Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Biohaven Pharmaceutical's price direction in advance. Along with the technical and fundamental analysis of Biohaven Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Biohaven to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.03) | |||
Jensen Alpha | (0.41) | |||
Total Risk Alpha | (0.76) | |||
Treynor Ratio | (0.16) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biohaven Pharmaceutical Holding. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Complementary Tools for Biohaven Stock analysis
When running Biohaven Pharmaceutical's price analysis, check to measure Biohaven Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biohaven Pharmaceutical is operating at the current time. Most of Biohaven Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Biohaven Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biohaven Pharmaceutical's price. Additionally, you may evaluate how the addition of Biohaven Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |
Is Biohaven Pharmaceutical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biohaven Pharmaceutical. If investors know Biohaven will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biohaven Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.73) | Return On Assets (0.46) | Return On Equity (0.84) |
The market value of Biohaven Pharmaceutical is measured differently than its book value, which is the value of Biohaven that is recorded on the company's balance sheet. Investors also form their own opinion of Biohaven Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Biohaven Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biohaven Pharmaceutical's market value can be influenced by many factors that don't directly affect Biohaven Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biohaven Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biohaven Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biohaven Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.